These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 37326755)

  • 21. Current and Future Therapies for Psoriasis with a Focus on Serotonergic Drugs.
    Martins AM; Ascenso A; Ribeiro HM; Marto J
    Mol Neurobiol; 2020 May; 57(5):2391-2419. PubMed ID: 32062841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and cost.
    Feldman SR; Garton R; Averett W; Balkrishnan R; Vallee J
    Expert Opin Pharmacother; 2003 Sep; 4(9):1525-33. PubMed ID: 12943482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatments for psoriasis and the risk of malignancy.
    Patel RV; Clark LN; Lebwohl M; Weinberg JM
    J Am Acad Dermatol; 2009 Jun; 60(6):1001-17. PubMed ID: 19344980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generalized pustular psoriasis: a review and update on treatment.
    Hoegler KM; John AM; Handler MZ; Schwartz RA
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1645-1651. PubMed ID: 29573491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination regimens of topical calcipotriene in chronic plaque psoriasis: systematic review of efficacy and tolerability.
    Ashcroft DM; Li Wan Po A; Williams HC; Griffiths CE
    Arch Dermatol; 2000 Dec; 136(12):1536-43. PubMed ID: 11115167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serious infection risk in children with psoriasis on systemic treatment: A propensity score-matched population-based study.
    Schneeweiss MC; Huang JT; Wyss R; Schneeweiss S; Merola JF
    J Am Acad Dermatol; 2020 Jun; 82(6):1337-1345. PubMed ID: 32142748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis.
    Maruani A; Samimi M; Stembridge N; Abdel Hay R; Tavernier E; Hughes C; Le Cleach L
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011541. PubMed ID: 30958563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultraviolet B Phototherapy for Psoriasis: Review of Practical Guidelines.
    Mehta D; Lim HW
    Am J Clin Dermatol; 2016 Apr; 17(2):125-33. PubMed ID: 26872953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PUVA combination therapy.
    Morison WL
    Photodermatol; 1985 Aug; 2(4):229-36. PubMed ID: 3903677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes associated with the use of biologic agents in moderate to severe psoriasis.
    Price J; Bhosle M; Feldman SR; Balkrishnan R
    J Drugs Dermatol; 2007 Mar; 6(3):259-67. PubMed ID: 17373187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of psoriasis. Part 1. Topical therapy and phototherapy.
    Lebwohl M; Ali S
    J Am Acad Dermatol; 2001 Oct; 45(4):487-98; quiz 499-502. PubMed ID: 11568737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic Review and Recommendations to Combine Newer Therapies With Conventional Therapy in Psoriatic Disease.
    Arora S; Das P; Arora G
    Front Med (Lausanne); 2021; 8():696597. PubMed ID: 34490293
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of Management Guidelines for Moderate-to-Severe Plaque Psoriasis: A Review of Phototherapy, Systemic Therapies, and Biologic Agents.
    Ighani A; Partridge ACR; Shear NH; Lynde C; Gulliver WP; Sibbald C; Fleming P
    J Cutan Med Surg; 2019; 23(2):204-221. PubMed ID: 30463416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paradoxical effects of cost reduction measures in managed care systems for treatment of severe psoriasis.
    Yentzer BA; Yelverton CB; Simpson GL; Simpson JF; Hwang W; Balkrishnan R; Feldman SR
    Dermatol Online J; 2009 Apr; 15(4):1. PubMed ID: 19450394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study.
    Christophers E; Segaert S; Milligan G; Molta CT; Boggs R
    J Dermatolog Treat; 2013 Jun; 24(3):193-8. PubMed ID: 22620684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinoid therapy for psoriasis.
    Yamauchi PS; Rizk D; Lowe NJ
    Dermatol Clin; 2004 Oct; 22(4):467-76, x. PubMed ID: 15450342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psoriasis phototherapy experience from a Lisbon unit: a still valid therapeutic approach in the 21st century.
    Carvalho R; Marques-Pinto G; Cardoso J
    Cutan Ocul Toxicol; 2013 Mar; 32(1):78-82. PubMed ID: 22250764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcipotriol/calcipotriene (Dovonex/Daivonex) in combination with phototherapy: a review.
    Koo J
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S59-61. PubMed ID: 9344187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developments in systemic immunomodulatory therapy for psoriasis.
    Berger EM; Gottlieb AB
    Curr Opin Pharmacol; 2007 Aug; 7(4):434-44. PubMed ID: 17627886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks.
    Naldi L; Griffiths CE
    Br J Dermatol; 2005 Apr; 152(4):597-615. PubMed ID: 15840088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.